Equities

Cambridge Cognition Holdings PLC

Cambridge Cognition Holdings PLC

Actions
Health CareHealth Care Providers
  • Price (GBX)45.00
  • Today's Change-1.40 / -3.02%
  • Shares traded6.71k
  • 1 Year change-55.00%
  • Beta1.2862
Data delayed at least 20 minutes, as of May 24 2024 14:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cambridge Cognition Holdings plc is a United Kingdom-based company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. The Company’s therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimer’s Disease, Autism Spectrum Disorder, Cognitive Safety, Core Cognitive Function, Depression, Down’s Syndrome, Drug Abuse Liability, Epilepsy, Huntington’s Disease, Multiple Sclerosis, Neuromuscular Disorders, Obsessive Compulsive Disorder, Parkinson’s Disease, Schizophrenia, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury.

  • Revenue in GBP (TTM)13.52m
  • Net income in GBP-3.51m
  • Incorporated2012
  • Employees80.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ENGAGE XR Holdings PLC3.14m-3.45m9.45m67.00--1.30--3.01-0.0072-0.00720.00650.01380.5704--2.8846,911.75-62.66-68.10-73.43-76.1689.7180.74-109.85-144.17----0.0101---4.6038.8032.49---52.83--
KRM22 PLC4.36m-4.23m9.85m45.00--7.74--2.26-0.1187-0.11870.12230.03560.4019--5.8596,955.55-38.99-36.84-61.95-49.9274.1084.63-97.02-138.63---0.83830.7663---0.2528--6.88------
Crimson Tide plc6.16m-295.00k10.06m52.00--1.3313.631.63-0.0449-0.04490.93611.150.6267--4.25---3.00-2.92-3.59-3.4986.2184.54-4.79-4.83---12.040.0813--15.0320.7576.27--27.43--
Shearwater Group PLC26.40m-7.80m10.25m99.00--0.217--0.3881-0.3276-0.32761.111.980.3858--2.28266,636.40-11.41-4.62-13.40-5.7126.0929.31-29.56-10.40---115.180.0062---25.6233.73-2,699.66--71.17--
ITIM Group Plc16.13m-892.00k10.30m173.00--0.987912.150.6385-0.0286-0.02860.51680.36940.8087--3.2393,236.99-4.470.1574-6.570.208631.2536.50-5.530.1877---25.760.0858--14.948.72-30.03--24.57--
essensys PLC24.08m-10.73m11.48m171.00--0.6413--0.477-0.1664-0.16640.3730.27680.80523.513.86140,807.00-35.89-19.06-45.87-24.1660.5361.83-44.58-26.991.61-321.600.067--8.408.96-45.44--43.70--
Induction Healthcare Group PLC11.82m-14.18m11.54m83.00--0.5098--0.9758-0.1535-0.15390.1280.24520.2573--6.43142,445.80-30.86---40.57--67.40---119.92-----3,768.500.004--78.18---105.40------
Arcontech Group PLC2.82m1.15m13.37m16.0011.661.7310.304.740.08570.08570.2110.57660.2874--2.17176,370.6011.6812.3615.1216.05----40.6333.96----0.066938.45-1.001.6260.521.3810.7421.91
Insig Ai PLC2.02m-17.56m13.46m112.00--0.8701--6.66-0.1722-0.17220.01970.14080.0691--10.4018,045.36-60.06---66.10--62.47---869.16-----29.180.1377--22.51---342.03------
4Global PLC5.94m767.49k13.57m25.0028.303.7611.412.280.01820.01820.20570.13711.35--2.51--17.43--23.95--75.60--12.91----28.110.1249--53.46--139.00------
Cambridge Cognition Holdings PLC13.52m-3.51m16.31m80.00--12.64--1.21-0.1021-0.10210.39080.03670.921413.483.81---23.92-14.82-209.06-563.6479.9078.14-25.96-14.180.5462-12.160.6648--7.1517.12-757.70--5.71--
Pebble Beach Systems Group PLC12.37m1.53m17.13m95.0011.5720.095.641.390.01190.01190.0970.00691.007.073.15--12.4512.4128.7230.0377.1575.7512.4012.810.70873.930.8693--10.776.1629.78--21.64--
GSTechnologies Ltd-903.37k-641.10k18.58m48.00--5.01-----0.0004-0.0006-0.00050.0019-0.1941-----18,820.12-13.77---17.35----------12.67--0.00--842.55---41.06------
Blackbird PLC1.94m-2.49m18.97m34.00--2.05--9.79-0.0068-0.00680.00530.02390.1728378.552.48---22.23-19.75-24.90-21.9993.5592.12-128.69-111.156.57--0.00---31.9517.36-30.07--45.08--
Ingenta PLC10.92m2.44m21.22m71.009.124.147.531.940.16020.16020.70950.3531.15--8.39153,845.1025.642.8344.025.9050.2544.0922.332.58--105.240.00127.793.02-6.59-18.998.17-13.142.83
Narf Industries PLC3.25m-14.50m21.67m0.00--15.03--6.66-0.0085-0.00850.00190.00090.8809--4.04---392.53---474.01---6.59---445.59-----0.12370.4061-------819.63------
Data as of May 24 2024. Currency figures normalised to Cambridge Cognition Holdings PLC's reporting currency: UK Pound GBX

Institutional shareholders

30.18%Per cent of shares held by top holders
HolderShares% Held
Canaccord Genuity Wealth Ltd.as of 05 Sep 20233.53m10.04%
Lombard Odier Asset Management (USA) Corp.as of 11 Jan 20232.85m8.11%
J.O. Hambro Capital Management Ltd.as of 27 Jan 20231.75m4.98%
Octopus Investments Ltd.as of 11 Jan 20231.43m4.07%
AXA Investment Managers UK Ltd.as of 11 Jan 20231.05m2.99%
More ▼
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.